← Back to Search

Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01

Houston, TX
N/A
Waitlist Available
Led By Niloy J Samadder
Research Sponsored by National Cancer Institute (NCI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* MAY2016-07-01 study participants for whom medical records are available and accessible
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at completion of study
Awards & highlights
No Placebo-Only Group

Summary

This study reviews post study clinical endoscopy reports in follow up to patients who participated in MAY2016-07-01 with weekly erlotinib for familial adenomatous polyposis. Reviewing follow up medical records may help researchers examine the extent of rapid progression of familiar adenomatous polyposis disease burden after discontinuation of weekly erlotinib.

See full description
Eligible Conditions
  • Adenomatous Polyposis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
* MAY2016-07-01 study participants for whom medical records are available and accessible

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at completion of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and at completion of study for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of participants who underwent surgical resection
Number of study participants exhibiting clinically significant progression of duodenal neoplasia after completion of study drug
Secondary study objectives
Number of participants with evidence of progression of upper GI disease

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (medical record review)Experimental Treatment1 Intervention
Patients who participated in MAY2016-07-01 undergo review of medical records.

Find a Location

Closest Location:Mayo Clinic in Rochester· Rochester, MN· 565 miles

Who is running the clinical trial?

National Cancer Institute (NCI)Lead Sponsor
14,057 Previous Clinical Trials
41,149,456 Total Patients Enrolled
Niloy J SamadderPrincipal InvestigatorMayo Clinic in Rochester
6 Previous Clinical Trials
3,061 Total Patients Enrolled
~9 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top